Whether human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) could heal luminal ulcers in Crohn’s disease.
By Pooja Toshniwal PahariaApr 25 2024Reviewed by Lily Ramsey, LLM In a recent study published in eBioMedicine, researchers investigated whether human umbilical cord -derived mesenchymal stem cells could heal luminal ulcers in Crohn’s disease patients.
Human umbilical cord MSCs have acquired popularity due to their immunomodulatory capabilities, simplicity of collection, limitless source of stem cells, low immunological rejection, and lack of tumorigenic features. The colon macroscopic damage index assessed the level of colonic inflammation. They analyzed colon samples under a microscope to establish histopathological scores .
They performed endoscopic assessments at the start of the trial and, after 12 weeks, obtained mucosal specimens from lesion margins for ribonucleic acid sequencing. The researchers excluded individuals with a history of pregnancy, CD complications, comorbidities, prior surgery, uncontrolled infections, or cancer in the past five years.
Results In preclinical studies, hUC-MSCs raised body weight while decreasing DAI, CMDI, and HPS scores in the TNBS-inflicted colitis murine model, with significant reductions in intestinal mucosal injury, edema, hyperemia, and ulcerations. The treatment dramatically enhanced RNA levels of tight junction proteins in the intestinal epithelium and intestinal pro-inflammatory genes .
Mesenchymal Stem Cells Stem Cells Umbilical Cord Colon Colonoscopy Efficacy Gene Genes Immunomodulatory Laboratory Macrophage Phosphorylation Research RNA Transcription
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Human neuron model identifies potential therapeutic targets for Alzheimer's diseaseWeill Cornell Medicine scientists have developed an innovative human neuron model that robustly simulates the spread of tau protein aggregates in the brain-;a process that drives cognitive decline in Alzheimer's disease and frontotemporal dementia.
続きを読む »
Investigational therapeutic shows promise in preclinical pancreatic cancer modelA new type of investigational therapeutic in development for pancreatic cancer has shown unprecedented tumor-fighting abilities in preclinical models of the disease, suggesting it has the potential to offer novel treatment options for nearly all pancreatic tumors, a comprehensive study has found.
続きを読む »
Novel pre-clinical models help advance therapeutic development for antibiotic-resistant bacterial infectionsThe A*STAR Infectious Diseases Labs (A*STAR ID Labs) and the Hackensack Meridian Health Center for Discovery and Innovation have teamed up to shed light on a concerning health issue—infections caused by a type of bacteria known as Klebsiella pneumoniae (Kp).
続きを読む »
Therapeutic potential of CD20 x CD3 bispecific antibodiesOn Monday, March 25th, 2024, the U.S. FDA declined approval for Regeneron’s Odronextamab for two forms of lymphoma due to concerns over the progress of ongoing confirmatory trials.
続きを読む »
Potential therapeutic target for small cell lung cancer discoveredNorthwestern Medicine investigators have discovered that inhibiting a chromatin remodeling complex associated with a particular gene in small-cell lung cancer (SCLC) cells may decrease cancer cell differentiation and tumor growth, according to findings published in Nature Communications.
続きを読む »
Alarmin molecule identified as therapeutic target for allergic respiratory diseasesOne of the molecules responsible for triggering the inflammation that causes allergic respiratory diseases, such as asthma and allergic rhinitis, has just been discovered by scientists from the CNRS, Inserm and the Université Toulouse III – Paul Sabatier.
続きを読む »